Steele P, Battock D, Pappas G, Genton E
Circulation. 1976 Apr;53(4):685-7. doi: 10.1161/01.cir.53.4.685.
Platelet survival time is frequently shortened in patients with coronary artery disease, and it is one of several factors that might contribute to graft occlusion after saphenous vein coronary artery bypass (CAB). In 35 patients with CAB, average platelet survival (autologous labeling with 51Chromium) was shortened in 20 with one or more saphenous vein grafts occluded and normal in 15 with all grafts open. Of 15 with all grafts open, individual levels of platelet survival were normal in 10 while in 20 with one or more grafts occluded platelet survival was normal in only one. Platelet survival was not altered by coronary surgery and nine of ten with shortened platelet survival pre-operatively had graft occlusion. Platelet survival did not correlate with either parent artery occlusion or serum lipoproteins. These findings suggest a relationship between shortened platelet survival and saphenous vein graft occlusion and suggest that platelet suppressant therapy might be useful in preventing graft occlusion.
冠心病患者的血小板存活时间常常缩短,这是导致隐静脉冠状动脉搭桥术(CAB)后移植血管闭塞的几个因素之一。在35例接受CAB的患者中,20例有一根或多根隐静脉移植血管闭塞,其平均血小板存活时间(用51铬进行自体标记)缩短,而15例所有移植血管通畅的患者,其血小板存活时间正常。在所有移植血管通畅的15例患者中,10例的个体血小板存活水平正常,而在20例有一根或多根移植血管闭塞的患者中,只有1例血小板存活时间正常。冠状动脉手术并未改变血小板存活时间,术前血小板存活时间缩短的10例患者中有9例发生了移植血管闭塞。血小板存活时间与冠状动脉闭塞或血清脂蛋白均无相关性。这些发现表明血小板存活时间缩短与隐静脉移植血管闭塞之间存在关联,并提示血小板抑制疗法可能有助于预防移植血管闭塞。